Page last updated: 2024-09-04

celastrol methyl ester and Carcinoma, Squamous Cell

celastrol methyl ester has been researched along with Carcinoma, Squamous Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Bi, Y; Cheng, X; Gong, Y; Guo, J; He, L; Ma, Q; Yu, W; Yu, X; Zhao, Q1
Feng, W; Li, X; Mou, Y; Wang, X; Wang, Y; Zhang, Y1
Ahmad, F; Al-Tamimi, M; Alam, M; Anver, R; Buddenkotte, J; Khan, AQ; M Mateo, J; Raza, SS; Steinhoff, M; Uddin, S1

Reviews

1 review(s) available for celastrol methyl ester and Carcinoma, Squamous Cell

ArticleYear
The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 154

    Topics: Carcinoma, Squamous Cell; Humans; Male; Mouth Neoplasms; Pentacyclic Triterpenes; Triterpenes; Tumor Microenvironment

2022

Other Studies

2 other study(ies) available for celastrol methyl ester and Carcinoma, Squamous Cell

ArticleYear
Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 92

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Pentacyclic Triterpenes; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck; Triterpenes

2021
Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Carcinoma, Squamous Cell; Humans; MAP Kinase Signaling System; Reactive Oxygen Species; Skin Neoplasms

2022